Clinical Trial Update: A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing dose-response effects of dietary resveratrol on lipid metabolism disorders completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Dyslipidemias | Phase 3 | Status: COMPLETED